Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol (2014) 4.34

Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr (2012) 3.48

Molecular pathology of age-related macular degeneration. Prog Retin Eye Res (2008) 3.35

Age-related macular degeneration. Lancet (2008) 3.34

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33

A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet (2003) 3.23

Oxidative damage and age-related macular degeneration. Mol Vis (1999) 2.97

Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91

Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Arch Ophthalmol (2010) 2.78

Epidemiology of age-related maculopathy: a review. Eur J Epidemiol (2003) 2.32

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol (2010) 2.32

Evaluation of transgenic tomato plants expressing an additional phytoene synthase in a fruit-specific manner. Proc Natl Acad Sci U S A (2002) 1.71

Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol (2006) 1.68

The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology (2012) 1.66

Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61

Zeaxanthin accumulation in the absence of a functional xanthophyll cycle protects Chlamydomonas reinhardtii from photooxidative stress. Plant Cell (2003) 1.58

Violet and blue light blocking intraocular lenses: photoprotection versus photoreception. Br J Ophthalmol (2006) 1.49

Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology (2002) 1.48

Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up. JAMA Ophthalmol (2015) 1.46

Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis. BMJ (2007) 1.46

Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry (2011) 1.43

Simple Raman instrument for in vivo detection of macular pigments. Appl Spectrosc (2005) 1.41

Rhizosphere communities of genetically modified zeaxanthin-accumulating potato plants and their parent cultivar differ less than those of different potato cultivars. Appl Environ Microbiol (2009) 1.40

Macular pigment and age related macular degeneration. Br J Ophthalmol (1999) 1.39

Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol (1998) 1.35

Prevention of age related macular degeneration. BMJ (2002) 1.34

Oxidative stress promotes ocular neovascularization. J Cell Physiol (2009) 1.28

Cholesterol in the retina: the best is yet to come. Prog Retin Eye Res (2014) 1.27

Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol (2007) 1.26

Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. Br J Ophthalmol (2006) 1.23

Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A Opt Image Sci Vis (2000) 1.19

Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis (2006) 1.18

Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium. Arch Biochem Biophys (2008) 1.18

Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging. Invest Ophthalmol Vis Sci (2013) 1.17

Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17

Body mass index and the incidence of visually significant age-related maculopathy in men. Arch Ophthalmol (2001) 1.17

Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy. Prog Retin Eye Res (2014) 1.17

Human ocular carotenoid-binding proteins. Photochem Photobiol Sci (2010) 1.16

Carotenoid intakes, assessed by food-frequency questionnaires (FFQs), are associated with serum carotenoid concentrations in the Jackson Heart Study: validation of the Jackson Heart Study Delta NIRI Adult FFQs. Public Health Nutr (2007) 1.15

Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage. Invest Ophthalmol Vis Sci (2011) 1.13

Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol (2010) 1.12

Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonica. Biochemistry (2007) 1.11

Genetic susceptibility to age related macular degeneration. J Med Genet (2000) 1.11

The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res (2009) 1.11

Effects of lutein and cholesterol on alkyl chain bending in lipid bilayers: a pulse electron spin resonance spin labeling study. Biophys J (1996) 1.10

Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology (2013) 1.08

Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration. Mol Vis (2010) 1.08

Lutein and zeaxanthin dietary intake and age related macular degeneration. Br J Ophthalmol (2006) 1.06

(R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage. Invest Ophthalmol Vis Sci (2005) 1.06

The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. Clinics (Sao Paulo) (2011) 1.04

Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. Mol Aspects Med (2012) 1.03

Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. Am J Clin Nutr (2010) 1.03

Healthy lifestyles related to subsequent prevalence of age-related macular degeneration. Arch Ophthalmol (2010) 1.02

Skin carotenoid status measured by resonance Raman spectroscopy as a biomarker of fruit and vegetable intake in preschool children. Eur J Clin Nutr (2012) 1.01

Neuroprotective effects of lutein in the retina. Curr Pharm Des (2012) 1.01

Resonance Raman detection of carotenoid antioxidants in living human tissue. J Biomed Opt (2006) 1.00

Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00

Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells. Free Radic Biol Med (2012) 1.00

Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients (2013) 0.99

Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr (2008) 0.98

Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res (2015) 0.98

Smoking and age-related macular degeneration: review and update. J Ophthalmol (2013) 0.97

Nutritional modulation of age-related macular degeneration. Mol Aspects Med (2012) 0.97

The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence. Nutr J (2003) 0.97

rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One (2009) 0.97

Plasma biomarkers of oxidative stress and genetic variants in age-related macular degeneration. Am J Ophthalmol (2011) 0.97

Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis (2008) 0.96

Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch Biochem Biophys (2010) 0.96

Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci (2007) 0.96

Pathological consequences of long-term mitochondrial oxidative stress in the mouse retinal pigment epithelium. Exp Eye Res (2012) 0.95

Is age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa? Clin Ophthalmol (2012) 0.95

The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. Am J Clin Nutr (2012) 0.95

Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol (2003) 0.95

Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). Invest Ophthalmol Vis Sci (2014) 0.95

Prevention of age-related macular degeneration. Int Ophthalmol (2010) 0.94

Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol (2011) 0.93

C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology (2010) 0.92

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD). Biogerontology (2013) 0.92

Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur J Nutr (2009) 0.92

Identification of alleles of carotenoid pathway genes important for zeaxanthin accumulation in potato tubers. Plant Mol Biol (2010) 0.91

Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Graefes Arch Clin Exp Ophthalmol (2013) 0.91

Age-related macular degeneration and recent developments: new hope for old eyes? Postgrad Med J (2007) 0.91

TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD. BMC Ophthalmol (2007) 0.90

The role of lutein in eye-related disease. Nutrients (2013) 0.89

Functional effect of Saffron supplementation and risk genotypes in early age-related macular degeneration: a preliminary report. J Transl Med (2013) 0.89

Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration. Br J Ophthalmol (2001) 0.88

Nutrition effects on ocular diseases in the aging eye. Invest Ophthalmol Vis Sci (2013) 0.88

Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center. Invest Ophthalmol Vis Sci (2012) 0.88

Linking the xanthophyll cycle with thermal energy dissipation. Photosynth Res (2003) 0.87

The short-term effects of antioxidant and zinc supplements on oxidative stress biomarker levels in plasma: a pilot investigation. Am J Ophthalmol (2012) 0.87

Characterization of the Role of β-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism. J Biol Chem (2015) 0.87

Effect of 1-year lutein supplementation on macular pigment optical density and visual function. Graefes Arch Clin Exp Ophthalmol (2011) 0.86

Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86

Race, iris color, and age-related macular degeneration. Trans Am Ophthalmol Soc (2000) 0.86

Genetic architecture controlling variation in grain carotenoid composition and concentrations in two maize populations. Theor Appl Genet (2013) 0.86

Regulation of signaling events involved in the pathophysiology of neovascular AMD. Mol Vis (2016) 0.85

Protective effects of epigallocatechin gallate after UV irradiation in cultured human retinal pigment epithelial cells. Korean J Ophthalmol (2007) 0.85

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.96

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol (1999) 8.92

Supernormal vision and high-resolution retinal imaging through adaptive optics. J Opt Soc Am A Opt Image Sci Vis (1997) 8.06

Current treatment of metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.15

Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03

Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab (1998) 3.69

Refractive Error Study in Children: results from Shunyi District, China. Am J Ophthalmol (2000) 3.62

Pluralistic ignorance and alcohol use on campus: some consequences of misperceiving the social norm. J Pers Soc Psychol (1993) 3.59

Refractive Error Study in Children: results from La Florida, Chile. Am J Ophthalmol (2000) 3.47

Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier. Analyst (1987) 3.25

Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21

Serum vitamin D concentrations among elderly people in Europe. Lancet (1995) 3.19

Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06

Prevalence of myopia in the United States. Arch Ophthalmol (1983) 3.00

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95

Epidemiologic aspects of uveal melanoma. Surv Ophthalmol (1988) 2.85

Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol (1992) 2.79

The barriers in protein folding. Nat Struct Biol (1994) 2.79

Familial aggregation of age-related maculopathy. Am J Ophthalmol (1997) 2.77

Reorganization of retinotopic cortical maps in adult mammals after lesions of the retina. Science (1990) 2.72

Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology (1998) 2.62

India-US case-control study of age-related cataracts. India-US Case-Control Study Group. Arch Ophthalmol (1989) 2.57

Ocular blood flow velocity in age-related macular degeneration. Ophthalmology (1995) 2.53

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology (1996) 2.41

Moral credentials and the expression of prejudice. J Pers Soc Psychol (2001) 2.41

Adverse reactions due to indocyanine green. Ophthalmology (1994) 2.30

A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27

Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol (2001) 2.27

Sunlight and cataract: an epidemiologic investigation. Am J Epidemiol (1977) 2.23

Recovery of visual acuity after retinal detachment involving the macula. Trans Am Ophthalmol Soc (1982) 2.17

Epidemiology of retinal detachment. Arch Ophthalmol (1982) 2.15

Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol (2001) 2.11

Topical proparacaine and suture removal after blepharoplasty. Arch Ophthalmol (1990) 1.94

Retinal manifestations of neurofibromatosis. Diagnosis and management. Arch Ophthalmol (1991) 1.88

Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol (1986) 1.86

Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med (2000) 1.86

The epidemiology of senile cataracts: a review. Am J Epidemiol (1983) 1.83

Evaluation of prior primary malignancy as a determinant of uveal melanoma. A case-control study. Ophthalmology (1989) 1.82

Carbon isotopic fractionation in heterotrophic microbial metabolism. Appl Environ Microbiol (1985) 1.77

Senile lens changes and diabetes in two population studies. Am J Ophthalmol (1981) 1.69

Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol (1996) 1.64

Clinical course of macular holes: the Eye Disease Case-Control Study. Arch Ophthalmol (1999) 1.64

Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol (1990) 1.62

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study. Am J Surg Pathol (1997) 1.58

Monochromatic ophthalmoscopy and fundus photography. The normal fundus. Arch Ophthalmol (1977) 1.58

Intraocular lens implantation versus no intraocular lens implantation in patients with chronic iridocyclitis and pars planitis. A randomized prospective study. Ophthalmology (1993) 1.58

Exposure of the U.S. population aged 6 years and older to cadmium: 1988-1994. Arch Environ Contam Toxicol (2000) 1.58

Clinical characteristics of choroidal neovascular membranes. Arch Ophthalmol (1987) 1.57

A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med (2000) 1.57

Low-dose aspirin and risks of cataract in a randomized trial of US physicians. Arch Ophthalmol (1991) 1.56

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Standardized illumination for visual acuity testing in clinical research. Am J Ophthalmol (1982) 1.56

A dose-response effect between a sunlight index and age-related cataracts. Italian-American Cataract Study Group. Ann Epidemiol (1994) 1.55

Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med (2001) 1.55

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol (2000) 1.53

Proton beam irradiation. An alternative to enucleation for intraocular melanomas. Ophthalmology (1980) 1.53

Comparison of the effects of two viscoelastic agents, Healon and Viscoat, on postoperative intraocular pressure after penetrating keratoplasty. Ophthalmic Surg (1990) 1.51

Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis (1985) 1.49

High intraocular pressure and survival: the Framingham Studies. Am J Ophthalmol (1999) 1.49

X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol (1988) 1.49

A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res (2003) 1.48

Influence of type and severity of pure forms of age-related cataract on visual acuity and contrast sensitivity. Italian American Cataract Study Group. Invest Ophthalmol Vis Sci (1994) 1.48

Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group. Invest Ophthalmol Vis Sci (1990) 1.48

Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med (2000) 1.47

Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology (1993) 1.46

Retinal arterial macroaneurysms: risk factors and natural history. Br J Ophthalmol (1990) 1.46

Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol (1986) 1.45

Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. Ophthalmology (1992) 1.45

Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci (2000) 1.43

Epidemiologic associations with cataract in the 1971-1972 National Health and Nutrition Examination Survey. Am J Epidemiol (1983) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Progression of nonproliferative diabetic retinopathy following cataract extraction. Arch Ophthalmol (1988) 1.41

Blood lead concentration and children's anthropometric dimensions in the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J Pediatr (1999) 1.40

Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology (1992) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Long-term results of proton beam irradiated uveal melanomas. Ophthalmology (1987) 1.37

Blindness caused by diabetic retinopathy. Am J Ophthalmol (1974) 1.36

Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol (1999) 1.35

Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34

Unilateral Purtscher's retinopathy. Ophthalmology (1980) 1.34

Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol (2000) 1.34

Central serous chorioretinopathy associated with inhaled or intranasal corticosteroids. Ophthalmology (1997) 1.33

Drusen characteristics in patients with exudative versus non-exudative age-related macular degeneration. Retina (1988) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

The gooseberry-zipper region of Drosophila: five genes encode different spatially restricted transcripts in the embryo. EMBO J (1987) 1.31

Blindness from glaucoma. Am J Ophthalmol (1975) 1.30

Irregular astigmatism following episcleral buckling procedure with the use of silicone rubber sponges. Arch Ophthalmol (1973) 1.29